Clinical Trial Update: Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1 [Phase 3]

View source ↗

Summary

A Phase 3 study comparing terlipressin to placebo for hepatorenal syndrome Type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatorenal Syndrome

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: Mallinckrodt | Conditions: Hepatorenal Syndrome | Phase 3 | Status: COMPLETED